PT - JOURNAL ARTICLE AU - Chen, Liying AU - Deng, Ou AU - Fang, Ting AU - Chen, Mei AU - Zhang, Xvfeng AU - Cong, Ruichen AU - Lu, Dingqi AU - Zhang, Runrun AU - Jin, Qun AU - Wang, Xinchang TI - Phenome-wide causal proteomics enhance systemic lupus erythematosus flare prediction: A study in Asian populations AID - 10.1101/2024.11.17.24317460 DP - 2024 Jan 01 TA - medRxiv PG - 2024.11.17.24317460 4099 - http://medrxiv.org/content/early/2024/11/18/2024.11.17.24317460.short 4100 - http://medrxiv.org/content/early/2024/11/18/2024.11.17.24317460.full AB - Objective Systemic lupus erythematosus (SLE) is a complex autoimmune disease characterized by unpredictable flares. This study aimed to develop a novel proteomics-based risk prediction model specifically for Asian SLE populations to enhance personalized disease management and early intervention.Methods A longitudinal cohort study was conducted over 48 weeks, including 139 SLE patients monitored every 12 weeks. Patients were classified into flare (n = 53) and non-flare (n = 86) groups. Baseline plasma samples underwent data-independent acquisition (DIA) proteomics analysis, and phenome-wide Mendelian randomization (PheWAS) was performed to evaluate causal relationships between proteins and clinical predictors. Logistic regression (LR) and random forest (RF) models were used to integrate proteomic and clinical data for flare risk prediction.Results Five proteins (SAA1, B4GALT5, GIT2, NAA15, and RPIA) were significantly associated with SLE Disease Activity Index-2K (SLEDAI-2K) scores and 1-year flare risk, implicating key pathways such as B-cell receptor signaling and platelet degranulation. SAA1 demonstrated causal effects on flare-related clinical markers, including hemoglobin and red blood cell counts. A combined model integrating clinical and proteomic data achieved the highest predictive accuracy (AUC = 0.769), surpassing individual models. SAA1 was highlighted as a priority biomarker for rapid flare discrimination.Conclusion The integration of proteomic and clinical data significantly improves flare prediction in Asian SLE patients. The identification of key proteins and their causal relationships with flare-related clinical markers provides valuable insights for proactive SLE management and personalized therapeutic approaches.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was supported by the Zhejiang Traditional Chinese Medical Modernization Special Project (grant number 2020ZX008).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the ethics committee of the Second Affiliated Hospital of Zhejiang Chinese Medical University (approval NO.2020-KL-002-377 59 IH01).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe mass spectrometry proteomics data generated in this study have been deposited in the Integrated Proteome Resources (iProX) database under the dataset identifier IPX0007978000. The data are publicly accessible through the iProX website (https://www.iprox.cn/page/). Additional datasets that support the findings of this study are available from the corresponding author upon reasonable request.